Multicentric evaluation of the new HemosIL Acustar® chemiluminescence ADAMTS13 activity assay.

Maria Cristina Pascual IzquierdoJorge M NietoTeresa FidalgoInés Gómez SeguíMaribel Díaz-RicartMarta Fernández DocampoJulio Del RioRamon Salinas

Published in: International journal of laboratory hematology (2020)

HemosIL AcuStar® is highly sensitive to detect ADAMTS13 values below 10% and 5%. A large prospective validation study is needed to corroborate its utility in clinical practice.

Keyphrases

clinical practice
molecularly imprinted
high throughput
sensitive detection
fluorescent probe
living cells
high resolution